Regeneron Pharmaceuticals Stock Price Prediction
| REGN Stock | USD 681.58 11.65 1.68% |
Oversold Vs Overbought
36
Oversold | Overbought |
Quarterly Earnings Growth 0.298 | EPS Estimate Next Quarter 11.77 | EPS Estimate Current Year 45.0171 | EPS Estimate Next Year 44.9674 | Wall Street Target Price 1 K |
Using Regeneron Pharmaceuticals hype-based prediction, you can estimate the value of Regeneron Pharmaceuticals from the perspective of Regeneron Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Regeneron Pharmaceuticals using Regeneron Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Regeneron using crowd psychology based on the activity and movement of Regeneron Pharmaceuticals' stock price.
Regeneron Pharmaceuticals Short Interest
An investor who is long Regeneron Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Regeneron Pharmaceuticals and may potentially protect profits, hedge Regeneron Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 960.757 | Short Percent 0.0201 | Short Ratio 2.44 | Shares Short Prior Month 1.9 M | 50 Day MA 749.2014 |
Regeneron Pharmaceuticals Hype to Price Pattern
Investor biases related to Regeneron Pharmaceuticals' public news can be used to forecast risks associated with an investment in Regeneron. The trend in average sentiment can be used to explain how an investor holding Regeneron can time the market purely based on public headlines and social activities around Regeneron Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Regeneron Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals Implied Volatility | 0.57 |
Regeneron Pharmaceuticals' implied volatility exposes the market's sentiment of Regeneron Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Regeneron Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Regeneron Pharmaceuticals stock will not fluctuate a lot when Regeneron Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Regeneron Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Regeneron because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Regeneron Pharmaceuticals after-hype prediction price | USD 680.03 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Regeneron contract
Based on the Rule 16, the options market is currently suggesting that Regeneron Pharmaceuticals will have an average daily up or down price movement of about 0.0356% per day over the life of the 2025-02-28 option contract. With Regeneron Pharmaceuticals trading at USD 681.58, that is roughly USD 0.24 . If you think that the market is fully incorporating Regeneron Pharmaceuticals' daily price movement you should consider acquiring Regeneron Pharmaceuticals options at the current volatility level of 0.57%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Regeneron |
Regeneron Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Regeneron Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regeneron Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Regeneron Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Regeneron Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Regeneron Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regeneron Pharmaceuticals' historical news coverage. Regeneron Pharmaceuticals' after-hype downside and upside margins for the prediction period are 678.06 and 762.55, respectively. We have considered Regeneron Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Regeneron Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Regeneron Pharmaceuticals is based on 3 months time horizon.
Regeneron Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Regeneron Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regeneron Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regeneron Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.55 | 1.96 | 13.45 | 0.23 | 7 Events / Month | 14 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
681.58 | 680.03 | 1.90 |
|
Regeneron Pharmaceuticals Hype Timeline
Regeneron Pharmaceuticals is at this time traded for 681.58. The entity has historical hype elasticity of -13.45, and average elasticity to hype of competition of -0.23. Regeneron is forecasted to decline in value after the next headline, with the price expected to drop to 680.03. The average volatility of media hype impact on the company price is about 8.02%. The price decrease on the next news is expected to be -1.9%, whereas the daily expected return is at this time at -0.55%. The volatility of related hype on Regeneron Pharmaceuticals is about 465.56%, with the expected price after the next announcement by competition of 681.35. About 91.0% of the company shares are owned by institutional investors. The book value of Regeneron Pharmaceuticals was at this time reported as 272.04. The company has Price/Earnings To Growth (PEG) ratio of 1.04. Regeneron Pharmaceuticals recorded earning per share (EPS) of 40.45. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Regeneron Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Regeneron Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Regeneron Pharmaceuticals' future price movements. Getting to know how Regeneron Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regeneron Pharmaceuticals may potentially react to the hype associated with one of its peers.
Regeneron Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Regeneron price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regeneron using various technical indicators. When you analyze Regeneron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Regeneron Pharmaceuticals Predictive Indicators
The successful prediction of Regeneron Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Regeneron Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Regeneron Pharmaceuticals based on analysis of Regeneron Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Regeneron Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regeneron Pharmaceuticals's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 159.78 | 157.7 | 141.93 | 73.33 | PTB Ratio | 3.41 | 3.61 | 3.25 | 5.22 |
Story Coverage note for Regeneron Pharmaceuticals
The number of cover stories for Regeneron Pharmaceuticals depends on current market conditions and Regeneron Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regeneron Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regeneron Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Regeneron Pharmaceuticals Short Properties
Regeneron Pharmaceuticals' future price predictability will typically decrease when Regeneron Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regeneron Pharmaceuticals often depends not only on the future outlook of the potential Regeneron Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regeneron Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 113.7 M | |
| Cash And Short Term Investments | 10.8 B |
Check out Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.298 | Earnings Share 40.45 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.